Russell Investments Group
EW icon

Russell Investments Group’s Edwards Lifesciences EW Stock Holding History

Russell Investments Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$207M Buy
2,288,745
+132,947
+6% +$11.1M 0.18% 87
2026
Q1 		$173M Buy
2,155,798
+333,412
+18% +$27.5M 0.19% 98
2025
Q4 		$155M Sell
1,822,386
-85,534
-4% -$7.02M 0.17% 113
2025
Q3 		$148M Buy
1,907,920
+79,385
+4% +$6.2M 0.17% 112
2025
Q2 		$143M Buy
1,828,535
+161,364
+10% +$12M 0.18% 104
2025
Q1 		$121M Buy
1,667,171
+145,156
+10% +$10.4M 0.17% 127
2024
Q4 		$113M Buy
1,522,015
+254,324
+20% +$17.8M 0.16% 127
2024
Q3 		$83.7M Buy
1,267,691
+606,580
+92% +$44.1M 0.12% 179
2024
Q2 		$61.1M Sell
661,111
-143,652
-18% -$12.7M 0.1% 213
2024
Q1 		$76.9M Sell
804,763
-315,262
-28% -$26.5M 0.12% 175
2023
Q4 		$85.4M Buy
1,120,025
+153,726
+16% +$10.7M 0.15% 145
2023
Q3 		$67M Buy
966,299
+465,862
+93% +$37.4M 0.13% 176
2023
Q2 		$47.1M Buy
500,437
+107,546
+27% +$9.35M 0.09% 247
2023
Q1 		$32.4M Buy
392,891
+142,656
+57% +$11.2M 0.06% 361
2022
Q4 		$18.7M Buy
250,235
+15,902
+7% +$1.23M 0.04% 531
2022
Q3 		$19.4M Sell
234,333
-616,717
-72% -$59.3M 0.04% 486
2022
Q2 		$81M Sell
851,050
-50,913
-6% -$5.27M 0.17% 137
2022
Q1 		$106M Sell
901,963
-22,607
-2% -$2.54M 0.18% 120
2021
Q4 		$120M Sell
924,570
-50,710
-5% -$5.92M 0.19% 107
2021
Q3 		$110M Buy
975,280
+9,280
+1% +$1.06M 0.19% 107
2021
Q2 		$100M Sell
966,000
-126,950
-12% -$12M 0.17% 125
2021
Q1 		$91.4M Sell
1,092,950
-74,640
-6% -$6.31M 0.16% 133
2020
Q4 		$106M Buy
1,167,590
+243,110
+26% +$20.2M 0.21% 92
2020
Q3 		$73.6M Buy
924,480
+604,505
+189% +$47.2M 0.16% 139
2020
Q2 		$22M Buy
319,975
+159,130
+99% +$11.3M 0.05% 439
2020
Q1 		$10.3M Sell
160,845
-58,623
-27% -$4.23M 0.03% 635
2019
Q4 		$17M Buy
219,468
+69,453
+46% +$5.42M 0.03% 621
2019
Q3 		$10.9M Sell
150,015
-9,108
-6% -$640K 0.02% 816
2019
Q2 		$9.81M Sell
159,123
-76,254
-32% -$4.61M 0.02% 896
2019
Q1 		$15M Buy
235,377
+57,435
+32% +$3.28M 0.03% 698
2018
Q4 		$9.03M Sell
177,942
-618,153
-78% -$31.3M 0.02% 858
2018
Q3 		$46M Buy
796,095
+101,160
+15% +$4.95M 0.09% 242
2018
Q2 		$33.8M Sell
694,935
-372,264
-35% -$17.4M 0.07% 311
2018
Q1 		$49.5M Buy
1,067,199
+147,636
+16% +$6.41M 0.08% 281
2017
Q4 		$35.1M Sell
919,563
-7,719
-0.8% -$283K 0.06% 388
2017
Q3 		$33.8M Sell
927,282
-144,066
-13% -$5.49M 0.06% 397
2017
Q2 		$42.2M Sell
1,071,348
-818,358
-43% -$29.9M 0.08% 325
2017
Q1 		$59.3M Sell
1,889,706
-320,586
-15% -$10M 0.11% 215
2016
Q4 		$69M Buy
+2,210,292
New +$71.6M 0.13% 165

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Russell Investments Group's EW Position: Q2 2026 in Review

Russell Investments Group increased its Edwards Lifesciences (EW) stake by 6.2% in Q2 2026, buying an estimated $11.1M and bringing the position to 2,288,745 shares worth $207M. The position accounts for 0.18% of the portfolio, ranked #87.

Russell Investments Group first reported a position in EW in Q4 2016 and has held it in 39 quarters since. 774 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Russell Investments Group held 2,288,745 shares of Edwards Lifesciences worth $207M as of Q2 2026.
  • Russell Investments Group bought 132,947 Edwards Lifesciences shares in Q2 2026, an estimated $11.1M.
  • Edwards Lifesciences made up 0.18% of Russell Investments Group's portfolio in Q2 2026, its #87 holding.
  • Russell Investments Group first reported a position in Edwards Lifesciences in Q4 2016 and has held it in 39 quarters since.
  • 774 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.